Smart immune cells take aim at Hard-to-Treat cancers

NCT ID NCT06051695

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment using a patient's own immune cells, called CAR T cells, that are specially designed to target and kill solid tumor cells while leaving healthy cells unharmed. It is for adults with certain advanced cancers, including lung, colon, pancreatic, ovarian, and mesothelioma, that have not responded to other treatments. The study has two phases: first to find a safe dose, and second to see if the treatment shrinks tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Banner Health

    RECRUITING

    Gilbert, Arizona, 85234, United States

  • Fred Hutchinson Cancer Center

    RECRUITING

    Seattle, Washington, 98109, United States

  • Mayo Clinic

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33606, United States

  • NYU Langone Medical Center

    RECRUITING

    New York, New York, 10016, United States

  • Stanford University

    RECRUITING

    Stanford, California, 94305, United States

  • The Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

  • UCLA Medical Center

    RECRUITING

    Los Angeles, California, 90404, United States

  • UCSD Moores Cancer Center

    RECRUITING

    La Jolla, California, 92093, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

  • Washington University

    RECRUITING

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.